Skip to content
AZBio Logo
  • Members
    • Why Join AZBio
    • Join AZBio
      • AZBio Member Application
    • Support AZBio
    • Member Directory
      • My Member Profile
    • Save with AZBio Purchasing Power
    • AZBio Career Center
  • News
    • In The Loop
    • Health Innovation Spotlights
    • AZBio.TV
    • Arizona Bio News from Business Wire
    • BIO News from Business Wire
  • Events
    • AZBio Trailblazer Awards
    • Looking back on Arizona Bioscience Week 2023
    • Arizona Bioscience Week 2024
    • White Hat Life Science Investor Conference 2024
  • Resources
    • AZBioPEERS
    • AZBioPEERS Mentoring Program
    • How a Professional Employer Org (PEO) Can Support Your Business
    • AZBio Career Center
      • Career Planning Portal
    • Telling Arizona’s Biotech Story
    • Arizona BioMap
    • Resource Library
  • Advocacy
    • AZBio Legislative Watch List 2023
    • AZBio Public Policy Principles
    • Voice of the Patient
    • Find My Legislator
    • Request to Speak Instructions
    • Arizona Congressional Delegation
    • 2023 Congressional Calendar
    • BIO Advocacy Tool Kit
    • Government Affairs Committee
    • Government Affairs Blog
  • About AZBio
    • What We Do
    • Arizona Bioindustry Fact Sheet
    • AZBio History
    • AZBio Staff
    • AZBio Board of Directors
    • Privacy Policy
  • Contact
  • Member Login
  • Menu

Tag Archives: Celgene

TGen Physician-In-Chief Dr. Daniel Von Hoff inducted today into exclusive Joshua Lederberg Society

Posted on Fri/14/FebruaryFri/14/February by AZBio

Dr. Von Hoff is honored for advancing FDA approved treatment benefiting pancreatic cancer patientsContinue reading→

Pancreatic cancer patient survival is ‘significantly higher’ with nab-paclitaxel, in study led by TGen and Scottsdale Healthcare

Posted on Wed/16/OctoberWed/16/October by AZBio

NEJM today publishes findings of international trial resulting in recent FDA approval of Abraxane (nab-paclitaxel) for patients with advanced pancreatic cancer.Continue reading→

FDA approves drug tested by Scottsdale Healthcare and TGen

Posted on Fri/6/SeptemberFri/6/September by AZBio

Abraxane now part of standard-of-care for patients with advanced pancreatic cancer, following studies at the Virginia G. Piper Cancer Center at Scottsdale Healthcare
Continue reading→

U.S. Food and Drug Administration Approves ABRAXANE® in Combination with Gemcitabine as First-Line Treatment of Patients with Metastatic Pancreatic Cancer

Posted on Fri/6/SeptemberFri/6/September by AZBio

-Approval Based on MPACT Study of ABRAXANE in Combination with Gemcitabine Demonstrating a Clinically Meaningful Increase in Overall Survival-

-First New Treatment Approved for Metastatic Adenocarcinoma of the Pancreas in Nearly 8 Years-Continue reading→

Blog Categories

Upcoming Events

  • BioFuture 2023
            Oct 4, 2023 - New York
  • The Medtech Conference
            Oct 9, 2023 - Anaheim
  • Bisnow International Life Sciences and Biotech Conference
            Oct 11, 2023 - Philadelphia
  • ASU Annual Diagnostics Summit
            Oct 19, 2023 -
  • The brain hates losing (and other news from neuroeconomics)
            Nov 2, 2023 - Tempe
  • Western Regional Valley Fever Workshop: Emerging public health problem and mitigation strategies
            Nov 3, 2023 - Phoenix
  • Comparative Medicine Symposium
            Nov 30, 2023 - Scottsdale
  • Comparative Medicine Symposium 2023 : Leveraging Naturally Occurring Diseases in Dogs to Advance Biomedical Innovations
            Nov 30, 2023 - Scottsdale
  • AZBio Trailblazer Awards
            Dec 14, 2023 - Phoenix
  • all events

Blog Archive

  • Click the image for the latest news about AZBio Members
  • Click the image to learn more
  • Click the image to learn more
  • Click the image to learn more
  • Click the image to learn more about AZBio Membership
  • Click the image to learn more
  • Click the image to enter the AZBio Career Center
  • Click the image to learn more about the AZBio/AZAdvances Public Information Campaign
  • Patients are why we do what we do. Click the image to listen to their stories.

Disclaimer
Privacy Statement (US) Privacy Statement (EU)
Cookie Policy (EU)
Privacy Statement (UK)
Cookie Policy (UK)
Do Not Sell My Personal Information

Copyright 2023 | Arizona Bioindustry Association, Inc.
A SiteOrigin Theme
Manage Cookie Consent
We use cookies to optimize our website and our service.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}